Research ArticleCANCER

Genomically informed small-molecule drugs overcome resistance to a sustained-release formulation of an engineered death receptor agonist in patient-derived tumor models

See allHide authors and affiliations

Science Advances  04 Sep 2019:
Vol. 5, no. 9, eaaw9162
DOI: 10.1126/sciadv.aaw9162
PDF Container

Navigate This Article